Ardelyx (ARDX) Retained Earnings (2013 - 2026)
Ardelyx's (ARDX) quarterly Retained Earnings came in at -$984.5 million in Q1 2026, down 5469788.89% YoY from N/an in Q1 2025, and down 3.97% on a QoQ basis from -$946.9 million in Q4 2025.
Ardelyx (ARDX) Retained Earnings (2013 - 2026) Analysis & Trends
Ardelyx (ARDX) has 14 years of Retained Earnings data on file, last reported at -$984.5 million in Q1 2026.
- Quarterly Retained Earnings fell 5469788.89% year-over-year to -$984.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$984.5 million (down 5469788.89% YoY) and the FY2025 annual result came in at -$946.9 million, down 6.96% from the prior year.
- Retained Earnings slipped to -$984.5 million in Q1 2026, from -$946.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $185000.0 in Q3 2024 to a low of -$984.5 million in Q1 2026.
- A 5-year average of -$456.7 million and a median of -$767.9 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings plunged 26361166.67% — and 2024, when it surged 192.04%.
- Tracing ARDX's Retained Earnings over 5 years: stood at -$780.1 million in 2022, then fell by 8.47% to -$846.2 million in 2023, then declined by 4.62% to -$885.3 million in 2024, then slipped by 6.96% to -$946.9 million in 2025, then slipped by 3.97% to -$984.5 million in 2026.
- The last three Retained Earnings figures came in at -$984.5 million (Q1 2026), -$946.9 million (Q4 2025), and $124000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | -1.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 Bn |
| Mar 31, 2026 | -984.54 Mn |
| Dec 31, 2025 | -946.94 Mn |
| Sep 30, 2025 | 124,000.00 |
| Jun 30, 2025 | -38,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -885.34 Mn |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | -889.18 Mn |
| Mar 31, 2024 | -872.70 Mn |
| Dec 31, 2023 | -846.20 Mn |
| Sep 30, 2023 | -201,000.00 |
| Jun 30, 2023 | -210,000.00 |
| Mar 31, 2023 | -20,000.00 |
| Dec 31, 2022 | -780.14 Mn |
| Sep 30, 2022 | -790.83 Mn |
| Jun 30, 2022 | -767.94 Mn |
| Mar 31, 2022 | -88,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | 3,000.00 |